UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Deregulation of the IGF axis in cancer: epidemiological evidence and potential therapeutic interventions

Endocrine-related cancer, 2003-12, Vol.10 (4), p.561-578

2003

Volltextzugriff (PDF)

Prostate cancer genes associated with TMPRSS2–ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts

British journal of cancer, 2010-02, Vol.102 (3), p.570-576

2010

Volltextzugriff (PDF)

Of mice and men: the evolution of animal welfare guidelines for cancer research

British journal of cancer, 2010-05, Vol.102 (11), p.1553-1554

2010

Volltextzugriff (PDF)

Hypersensitivity reactions from taxol

Journal of clinical oncology, 1990-07, Vol.8 (7), p.1263-1268

1990

Volltextzugriff (PDF)

Hypersensitivity reactions to teniposide (VM-26): an analysis

Journal of clinical oncology, 1986-08, Vol.4 (8), p.1262-1269

1986

Volltextzugriff (PDF)

A molecular cytogenetic approach to studying platinum resistance

Journal of inorganic biochemistry, 1999-10, Vol.77 (1), p.95-104

1999

Volltextzugriff (PDF)

Biotransformation and elimination of [2-14C]-1-(2-deoxy-2'-fluoro-beta-D -arabinofuranosyl)-5-iodocytosine in immunosuppressed patients with herpesvirus infections

Antimicrobial Agents and Chemotherapy, 1985-05, Vol.27 (5), p.733-738

1985

Volltextzugriff (PDF)

Pentostatin in Hairy Cell Leukemia: Treatment by the Special Exception Mechanism

JNCI : Journal of the National Cancer Institute, 1989-03, Vol.81 (6), p.448-453

1989

Volltextzugriff (PDF)

Acivicin: a new glutamine antagonist in clinical trials

Journal of clinical oncology, 1984-09, Vol.2 (9), p.1064-1071

1984

Volltextzugriff (PDF)

Etoposide (VP-16-213). Current status of an active anticancer drug

The New England journal of medicine, 1985-03, Vol.312 (11), p.692-700

1985

Volltextzugriff (PDF)

Central nervous system toxicity of fludarabine phosphate

Cancer treatment reports, 1986-10, Vol.70 (10), p.1225

1986

Volltextzugriff (PDF)

Tamoxifen metabolic patterns within a glioma patient population treated with high‐dose tamoxifen

British journal of clinical pharmacology, 1997-02, Vol.43 (2), p.189-193

1997

Volltextzugriff (PDF)

Anthracycline analogs: the past, present, and future

Cancer chemotherapy and pharmacology, 1986-01, Vol.18 (3), p.185-197

1986

Volltextzugriff (PDF)

Hormones in cancer

Rational drug therapy, 1982-11, Vol.16 (11), p.1

Leyland-Jones, B

1982

Volltextzugriff (PDF)

Phase 1/2 pilot study of methotrexate-laurocapram topical gel for the treatment of patients with early-stage mycosis fungoides

Archives of dermatology (1960), 2003-05, Vol.139 (5), p.624

2003

Volltextzugriff (PDF)

Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia

Cancer research (Chicago, Ill.), 1985-03, Vol.45 (3), p.1408-1412

1985

Volltextzugriff (PDF)

Didemnin B. The first marine compound entering clinical trials as an antineoplastic agent

Investigational new drugs, 1986-01, Vol.4 (3), p.279-284

1986

Volltextzugriff (PDF)

Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study

Nature medicine, 2019-05, Vol.25 (5), p.744-750

2019

Volltextzugriff (PDF)

Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer

Cancer research (Chicago, Ill.), 1983-12, Vol.43 (12), p.6096-6101

1983

Volltextzugriff (PDF)

A strategy for the development of two clinically active cisplatin analogs : CBDCA and CHIP

Cancer chemotherapy and pharmacology, 1990, Vol.25 (6), p.395-404

1990

Volltextzugriff (PDF)

A phase I bioavailability and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered via nasogastric tube

Cancer research (Chicago, Ill.), 1991-04, Vol.51 (7), p.1803-1810

1991

Volltextzugriff (PDF)

2'-Fluoro-5-iodoarabinosylcytosine, a new potent antiviral agent: efficacy in immunosuppressed individuals with herpes zoster

The Journal of infectious diseases, 1986-09, Vol.154 (3), p.430-436

1986

Volltextzugriff (PDF)

Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU)

Cancer treatment reports, 1985-01, Vol.69 (1), p.55

1985

Volltextzugriff (PDF)

Deoxycytidine and deoxythymidine kinase activities in plasma of mice and patients with neoplastic disease

Cancer research (Chicago, Ill.), 1982-06, Vol.42 (6), p.2514-2517

1982

Volltextzugriff (PDF)

Protein-Coding and MicroRNA Biomarkers of Recurrence of Prostate Cancer Following Radical Prostatectomy

The American journal of pathology, 2011-07, Vol.179 (1), p.46-54

2011

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Deregulation of the IGF axis in cancer: epidemiological evidence and potential therapeutic interventions

Prostate cancer genes associated with TMPRSS2–ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts

Of mice and men: the evolution of animal welfare guidelines for cancer research

Hypersensitivity reactions from taxol

Hypersensitivity reactions to teniposide (VM-26): an analysis

A molecular cytogenetic approach to studying platinum resistance

Biotransformation and elimination of [2-14C]-1-(2-deoxy-2'-fluoro-beta-D -arabinofuranosyl)-5-iodocytosine in immunosuppressed patients with herpesvirus infections

Pentostatin in Hairy Cell Leukemia: Treatment by the Special Exception Mechanism

Acivicin: a new glutamine antagonist in clinical trials

Etoposide (VP-16-213). Current status of an active anticancer drug

Central nervous system toxicity of fludarabine phosphate

Tamoxifen metabolic patterns within a glioma patient population treated with high‐dose tamoxifen

Anthracycline analogs: the past, present, and future

Hormones in cancer

Phase 1/2 pilot study of methotrexate-laurocapram topical gel for the treatment of patients with early-stage mycosis fungoides

Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia

Didemnin B. The first marine compound entering clinical trials as an antineoplastic agent

Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study

Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer

A strategy for the development of two clinically active cisplatin analogs : CBDCA and CHIP

A phase I bioavailability and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered via nasogastric tube

2'-Fluoro-5-iodoarabinosylcytosine, a new potent antiviral agent: efficacy in immunosuppressed individuals with herpes zoster

Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU)

Deoxycytidine and deoxythymidine kinase activities in plasma of mice and patients with neoplastic disease

Protein-Coding and MicroRNA Biomarkers of Recurrence of Prostate Cancer Following Radical Prostatectomy

Aktive Filter

Suchergebnisse filtern